Results 341 to 350 of about 743,931 (363)

Thrombotic Events Associated with C1 Esterase Inhibitor Products in Patients with Hereditary Angioedema: Investigation from the United States Food and Drug Administration Adverse Event Reporting System Database

Pharmacotherapy, 2012
P. Gandhi, W. M. Gentry, M. Bottorff
semanticscholar   +1 more source

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

Ca-A Cancer Journal for Clinicians, 2018
Farhad Islami, Ann Goding Sauer, Kimberly D Miller   +2 more
exaly  

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2014
Robert A Smith, Shinya Matsuda
exaly  

Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database.

Heart Rhythm, 2004
R. Hauser, Linda M. Kallinen
semanticscholar   +1 more source

United States Food & Drug Administration

2004
openaire   +2 more sources

The burden of rare cancers in the United States

Ca-A Cancer Journal for Clinicians, 2017
Carol E Desantis
exaly  

Pharmacogenomics in the Assessment of Therapeutic Risks versus Benefits: Inside the United States Food and Drug Administration

Pharmacotherapy, 2011
I. Zineh, M. Pacanowski
semanticscholar   +1 more source

Minimizing the burden of cancer in the United States: Goals for a high‐performing health care system

Ca-A Cancer Journal for Clinicians, 2019
K Robin Yabroff, Ted Gansler, Otis W Brawley   +2 more
exaly  

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2017
Robert A Smith, Stacey A Fedewa, Otis W Brawley   +2 more
exaly  

Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system

Current Opinion in Anaesthesiology, 2010
Kylene Halloran, P. Barash
semanticscholar   +1 more source